Central to iProgen’s innovative efforts is an assortment of pioneering protein delivery technologies and extensive experience and expertise in antibody payload conjugation. We have developed conditionally activated antibody delivery and internalization technologies (Smart Antibodies^TM) that can boost existing antibody and ADC therapies. Additionally, we’re investigating a wider range of payloads, including oligonucleotides, peptides, PROTAC, lipid and even sugar.